CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer - Wikidata - awgldk - TriplyDB

CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer

CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer

http://www.wikidata.org/entity/Q34043804

about

Update in lung cancer and mesothelioma 2012 Regulation of tumor metastasis by myeloid-derived suppressor cells Progression and metastasis of lung cancer Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome Myeloid-derived suppressor cells in the development of lung cancer.Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease.Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer.A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy Complexity and challenges in defining myeloid-derived suppressor cells Enhanced circulating ILC2s accompany by upregulated MDSCs in patients with asthma.Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer.Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression.Monocytic myeloid-derived suppressor cells as a potent suppressor of tumor immunity in non-small cell lung cancer.Clinical evaluation of systemic and local immune responses in cancer: time for integration.Myeloid-derived suppressor cell heterogeneity in human cancers.The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.Myeloid-derived suppressor cells as effectors of immune suppression in cancer.On the origin of myeloid-derived suppressor cells.Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.Myeloid-Derived Suppressor Cells.CD14(+)S100A9(+) myeloid-derived suppressor cells portend decreased survival in patients with advanced lung cancer.Ascites-derived IL-6 and IL-10 synergistically expand CD14+HLA-DR-/low myeloid-derived suppressor cells in ovarian cancer patients.Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients.Metformin-induced reduction of CD39 and CD73 blocks myeloid-derived suppressor cell activity in patients with ovarian cancer.S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB.Downregulation of L-arginine metabolism in dendritic cells induces tolerance to exogenous antigen.Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation.CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer.Expansion of myeloid-derived suppressor cells in chronic obstructive pulmonary disease and lung cancer: potential link between inflammation and cancer.Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer.Circulating and tumor-infiltrating myeloid-derived suppressor cells in cervical carcinoma patients.Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies

P2860

Q24619675-571E6CAB-AB4E-4A03-985E-6B611DACB5FB Q27022125-B737E11C-840C-439D-B43A-96C3F011F19F Q28066865-096EB719-86F9-4709-BE84-A674E47D92EA Q28084627-3F69895A-4372-4242-820E-45BE66557694 Q28256749-1959AF94-04F1-46D5-B6BB-511265B464D0 Q29248715-0A8B22E8-8AE0-48D2-A713-AFC89B508FE5 Q33555717-484261B2-E597-4249-9F79-7F9231C356B1 Q33564156-5B2D4DF0-C1A8-412D-8026-88738D34C59C Q34517267-CF1BEE83-C656-4E73-86CF-89C1B26E40E4 Q34555169-423DBEE7-A34D-418C-ACDD-E765AB6DAB78 Q34570094-F8658DD6-B048-4D27-A144-B6620EFAFBE8 Q34600087-3370A755-4636-44BA-AC6A-3650C9B50DA9 Q34810257-CA593365-8941-4DA0-B344-CC214876134B Q35509317-D160B2ED-6F03-4206-8425-BEA1D2F76F3E Q35740929-1AE904FB-A1F0-4732-8DB2-458D91AB81E4 Q36112558-F055677F-61D6-42F2-98C2-7A66AA57C000 Q36738775-C84B59DD-9C69-4DED-B90A-F2647053FD3E Q37581919-5BCA298C-3A44-4FC1-8CDC-88359EA27411 Q38150174-E1326267-D92B-49CF-8F48-79A65F7C6BCF Q38223250-B3C81646-675D-4452-BF62-7A54D9DC5F9E Q38264982-4EDCD9D1-A25C-4382-B6B3-F7E5954AAF9D Q38702891-EFC1DAF0-5E52-488A-A747-93D2A71C4E0E Q38864758-22FA8B45-6E60-4F2F-837B-8DB816522335 Q38968944-24D9AA5C-0ED9-4612-97D1-DED84E11433A Q39896275-68270DB2-4AE2-4023-9C10-A48C9490D34A Q40385399-45FDFECF-B80B-4CA9-9D70-BC64871AD557 Q43046155-7F977C4A-26F8-46F3-9759-3CEBADF03414 Q45813459-39C8EBEA-DC5B-477D-A09E-9845F1C57857 Q45936373-2B76075D-6B8A-48A4-B45A-A498AEADFC2E Q47640229-78FC3AF7-E07A-4EB3-89AF-B9DC2FCED5AE Q50318458-6CA55433-0822-4EEE-A911-9908A24C5511 Q50335929-06E871F7-A9B6-4051-AFAE-6FEE48904048 Q51176869-4C1758D7-2AE2-420C-9277-8456BA87095D Q52763511-7ED61816-5FC9-4E3C-AB88-15338718A2C0 Q53449110-A93B76FB-B0B6-4699-85F0-50AAEB76CA28 Q54918600-88A5F3D9-9FEA-4124-8A41-45D1095723A4 Q54965346-F836DAC8-69F6-40B3-BE80-E600EC2E64ED Q57138311-E0C254AA-5FFB-4AD3-A622-3D52C9CEE306

P2860

CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer

http://www.wikidata.org/entity/Q34043804

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

CD14

@nl

CD14(+)S100A9(+) monocytic mye ...... in non-small cell lung cancer

@ast

CD14(+)S100A9(+) monocytic mye ...... in non-small cell lung cancer

@en

type

label

CD14

@nl

CD14(+)S100A9(+) monocytic mye ...... in non-small cell lung cancer

@ast

CD14(+)S100A9(+) monocytic mye ...... in non-small cell lung cancer

@en

prefLabel

CD14

@nl

CD14(+)S100A9(+) monocytic mye ...... in non-small cell lung cancer

@ast

CD14(+)S100A9(+) monocytic mye ...... in non-small cell lung cancer

@en

P1433

Q34043804-82907BB2-D2BE-4936-B79C-486531450947

P1476

Q34043804-3B3861A2-613E-49E6-98B4-556304042D0E

P2093

Q34043804-10F057D5-0F9C-4F3D-9F0F-86F90688281A

Q34043804-2CE0123B-B406-4319-8B50-F017B45D7D6C

Q34043804-334C0C38-7C08-463A-B7A3-846DEA26E792

Q34043804-393D2128-BF6D-4505-BD22-55599544CBC8

Q34043804-3A40DFB1-E1FD-49DC-812D-73AE99942CB0

Q34043804-5A178CD9-07A2-4206-A6CC-323CF97BC86B

Q34043804-62C6DD6F-3ACA-43C9-835A-38394974BF54

Q34043804-66E1ADC8-BFA7-4A67-BFA6-C7EC4A392CAD

Q34043804-946AFC84-3A2D-43DF-A53B-2801E750CC06

Q34043804-ABE479AD-41E1-41EA-B1FF-33CED3D0D33E

P2860

Q34043804-106FB182-F5DA-429A-994A-E930C145B866

Q34043804-13B31BB8-B416-4C41-AFD0-5EF4206E6F77

Q34043804-177B6E9E-4E04-4286-A9ED-C5CF24565480

Q34043804-26D54927-A61E-4CC7-B054-401DFBDE0C8C

Q34043804-293E05D0-FEEA-4E06-9D7A-92C7375125F2

Q34043804-505C419F-ECA2-4DAB-B992-7C92BAE1DB72

Q34043804-5A438EE3-CD9D-4DB1-9B5D-D91F8FCA537E

Q34043804-5EB78B2E-0750-489A-9EE1-EB47E71BB5BF

Q34043804-6469F81D-9431-4209-B8A4-5CF8B5ECFB32

Q34043804-7166E661-D16D-4FDE-80EF-BF6D003EDFB3

P304

Q34043804-76FF62D7-7FD0-4055-B82D-7A166B119ECC

P31

Q34043804-86279946-914A-498A-8D96-8C8B9EF1F8AF

P356

Q34043804-D558EA7F-2B41-4629-9256-9EE85A32907C

P407

Q34043804-0C3B9542-C63E-4F39-81E8-14D1B955A2E3

P433

Q34043804-6A1DFB99-795C-4D5F-89F7-EA956B67E18D

P478

Q34043804-5D9A1ED8-15BA-435C-BA46-2A50B825684E

P577

Q34043804-5F67CACA-0EDB-4950-AF3B-796E66934363

P698

Q34043804-05CCFFB3-8FAE-4BAB-8234-D55593AAFD07

P932

Q34043804-338520FA-BD2A-4644-8C9D-D64746DF0D91

P356

RCCM.201204-0636OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

CD14(+)S100A9(+) monocytic mye ...... in non-small cell lung cancer

@en

P2093

Chien-Da Huang

http://www.w3.org/2001/XMLSchema#string

Chih-Shi Kuo

http://www.w3.org/2001/XMLSchema#string

Chih-Teng Yu

http://www.w3.org/2001/XMLSchema#string

Chun-Hua Wang

http://www.w3.org/2001/XMLSchema#string

Chun-Liang Chou

http://www.w3.org/2001/XMLSchema#string

Fu-Tsai Chung

http://www.w3.org/2001/XMLSchema#string

Han-Pin Kuo

http://www.w3.org/2001/XMLSchema#string

Kang-Yun Lee

http://www.w3.org/2001/XMLSchema#string

Lu-Wei Kuo

http://www.w3.org/2001/XMLSchema#string

Po-Hao Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Myeloid-derived suppressor cells: linking inflammation and cancer

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells

Myeloid-derived suppressor cells as regulators of the immune system

Regulation of immune responses by L-arginine metabolism

Immunosuppressive strategies that are mediated by tumor cells

Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.

P304

1025-1036

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201204-0636OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22955317

http://www.w3.org/2001/XMLSchema#string

P932

4132576

http://www.w3.org/2001/XMLSchema#string